
ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.
TOKYO,Jan. 28,2025-- ThinkCyte,a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments,announced today that it will begin the pre-commercial